Patents by Inventor Dong LONG

Dong LONG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SOLID FORM OF AROMATIC COMPOUND AND PREPARATION METHOD THEREFOR
    Publication number: 20220220075
    Abstract: The present application relates to a solid form of a compound of Formula (I), a method for preparing the solid form, a pharmaceutical composition comprising the solid form, and uses of the solid form in preparing a medicament for treating or preventing peroxisome proliferator-activated receptor (PPAR)-related diseases such as nonalcoholic fatty liver disease (NAFLD).
    Type: Application
    Filed: May 21, 2020
    Publication date: July 14, 2022
    Applicant: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
    Inventors: Shidong YI, Tianming WANG, Zhuan WU, Long LI, Chengxi YANG, Zhiquan SONG, Dong LONG, Qiang TIAN, Hongmei SONG, Tongtong XUE, Jingyi WANG
  • Aromatic compound, pharmaceutical composition and use thereof
    Patent number: 11332457
    Abstract: The invention relates to an aromatic compound, pharmaceutical composition comprising the same, and a method for preparing the compound and an intermediate thereof. The invention also relates to use of the compound for the manufacture of a medicament for the prevention or treatment of a PPAR-related disease.
    Type: Grant
    Filed: November 15, 2018
    Date of Patent: May 17, 2022
    Assignee: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
    Inventors: Jiawang Zhu, Zhiquan Song, Dong Long, Lichun Wang, Jingyi Wang
  • Aromatic compound, pharmaceutical composition and use thereof
    Patent number: 11261170
    Abstract: The invention relates to an aromatic compound, pharmaceutical composition comprising the same, and a method for preparing the compound and an intermediate thereof. The invention also relates to use of the compound for the manufacture of a medicament for the prevention or treatment of a PPAR-related disease.
    Type: Grant
    Filed: May 20, 2020
    Date of Patent: March 1, 2022
    Assignee: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
    Inventors: Jiawang Zhu, Zhiquan Song, Dong Long, Lichun Wang, Jingyi Wang
  • Azetidine derivative, preparation method therefor, and use thereof
    Patent number: 11045455
    Abstract: The present invention relates to an azetidine derivative for use as a Janus kinase (JAK) inhibitor, a drug composition comprising same, a preparation method therefor, and a use thereof in the treatment of JAK-related diseases comprising, for example, inflammatory diseases, autoimmune diseases, and cancers.
    Type: Grant
    Filed: January 16, 2020
    Date of Patent: June 29, 2021
    Assignee: SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
    Inventors: Yinong Xie, Zejin You, Zhiwen Deng, Jun Zhu, Ao Wang, Yan Feng, Dong Long, Hong Zeng, Hongmei Song, Qijun Ye, Wei Qi, Donghai Su, Lichun Wang, Jingyi Wang
  • AROMATIC COMPOUND, PHARMACEUTICAL COMPOSITION AND USE THEREOF
    Publication number: 20200277277
    Abstract: The invention relates to an aromatic compound, pharmaceutical composition comprising the same, and a method for preparing the compound and an intermediate thereof. The invention also relates to use of the compound for the manufacture of a medicament for the prevention or treatment of a PPAR-related disease.
    Type: Application
    Filed: May 20, 2020
    Publication date: September 3, 2020
    Applicant: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
    Inventors: Jiawang ZHU, Zhiquan SONG, Dong LONG, Lichun WANG, Jingyi WANG
  • AROMATIC COMPOUND, PHARMACEUTICAL COMPOSITION AND USE THEREOF
    Publication number: 20200239429
    Abstract: The invention relates to an aromatic compound, pharmaceutical composition comprising the same, and a method for preparing the compound and an intermediate thereof. The invention also relates to use of the compound for the manufacture of a medicament for the prevention or treatment of a PPAR-related disease.
    Type: Application
    Filed: November 15, 2018
    Publication date: July 30, 2020
    Applicant: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
    Inventors: Jiawang ZHU, Zhiquan SONG, Dong LONG, Lichun WANG, Jingyi WANG
  • AZETIDINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF
    Publication number: 20200147062
    Abstract: The present invention relates to an azetidine derivative for use as a Janus kinase (JAK) inhibitor, a drug composition comprising same, a preparation method therefor, and a use thereof in the treatment of JAK-related diseases comprising, for example, inflammatory diseases, autoimmune diseases, and cancers.
    Type: Application
    Filed: January 16, 2020
    Publication date: May 14, 2020
    Applicant: SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
    Inventors: Yinong XIE, Zejin YOU, Zhiwen DENG, Jun ZHU, Ao WANG, Yan FENG, Dong LONG, Hong ZENG, Hongmei SONG, Qijun YE, Wei QI, Donghai SU, Lichun WANG, Jingyi WANG
  • AZETIDINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF
    Publication number: 20190060291
    Abstract: The present invention relates to an azetidine derivative for use as a Janus kinase (JAK) inhibitor, a drug composition comprising same, a preparation method therefor, and a use thereof in the treatment of JAK-related diseases comprising, for example, inflammatory diseases, autoimmune diseases, and cancers.
    Type: Application
    Filed: October 24, 2018
    Publication date: February 28, 2019
    Applicant: SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
    Inventors: YINONG XIE, Zejin YOU, Zhiwen DENG, Jun ZHU, Ao WANG, Yan FENG, Dong LONG, Hong ZENG, Hongmei SONG, Qijun YE, Wei QI, Donghai SU, Lichun WANG, Jingyi WANG
  • Azetidine derivative, preparation method therefor, and use thereof
    Patent number: 10159662
    Abstract: The present invention relates to an azetidine derivative for use as a Janus kinase (JAK) inhibitor, a drug composition comprising same, a preparation method therefor, and a use thereof in the treatment of JAK-related diseases comprising, for example, inflammatory diseases, autoimmune diseases, and cancers.
    Type: Grant
    Filed: December 8, 2016
    Date of Patent: December 25, 2018
    Assignee: SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
    Inventors: Yinong Xie, Zejin You, Zhiwen Deng, Jun Zhu, Ao Wang, Yan Feng, Dong Long, Hong Zeng, Hongmei Song, Qijun Ye, Wei Qi, Donghai Su, Lichun Wang, Jingyi Wang
  • AZETIDINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF
    Publication number: 20180289680
    Abstract: The present invention relates to an azetidine derivative for use as a Janus kinase (JAK) inhibitor, a drug composition comprising same, a preparation method therefor, and a use thereof in the treatment of JAK-related diseases comprising, for example, inflammatory diseases, autoimmune diseases, and cancers.
    Type: Application
    Filed: December 8, 2016
    Publication date: October 11, 2018
    Applicant: SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
    Inventors: Yinong XIE, Zejin YOU, Zhiwen DENG, Jun ZHU, Ao WANG, Yan FENG, Dong LONG, Hong ZHENG, Hongmei SONG, Qijun YE, Wei Qi, Donghai SU, Lichun WANG, Jingyi WANG